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Abstract
Background: Many tuberculosis (TB) patients incur catastrophic costs. Active case finding (ACF) may have socio-
protective properties that could contribute to the WHO End TB Strategy target of zero TB-affected families suffering
catastrophic costs, but available evidence remains limited. This study measured catastrophic cost incurrence and
socioeconomic impact of an episode of TB and compared those socioeconomic burdens in patients detected by
ACF versus passive case finding (PCF).
Methods: This cross-sectional study fielded a longitudinal adaptation of the WHO TB patient cost survey alongside
an ACF intervention from March 2018 to March 2019. The study was conducted in six intervention (ACF) districts
and six comparison (PCF) districts of Ho Chi Minh City, Viet Nam. Fifty-two TB patients detected through ACF and
46 TB patients in the PCF cohort were surveyed within two weeks of treatment initiation, at the end of the
intensive phase of treatment, and after treatment concluded. The survey measured income, direct and indirect
costs, and socioeconomic impact based on which we calculated catastrophic cost as the primary outcome. Local
currency was converted into US$ using the average exchange rates reported by OANDA for the study period
(VNĐ1 = US$0.0000436, 2018–2019). We fitted logistic regressions for comparisons between the ACF and PCF
cohorts as the primary exposures and used generalized estimating equations to adjust for autocorrelation.
Results: ACF patients were poorer than PCF patients (multidimensional poverty ratio: 16 % vs. 7 %; p = 0.033), but
incurred lower median pre-treatment costs (US$18 vs. US$80; p < 0.001) and lower median total costs (US$279 vs.
US$894; p < 0.001). Fewer ACF patients incurred catastrophic costs (15 % vs. 30 %) and had lower odds of
catastrophic cost (aOR = 0.17; 95 % CI: [0.05, 0.67]; p = 0.011), especially during the intensive phase (OR = 0.32; 95 %
CI: [0.12, 0.90]; p = 0.030). ACF patient experienced less social exclusion (OR = 0.41; 95 % CI: [0.18, 0.91]; p = 0.030),
but more often resorted to financial coping mechanisms (OR = 5.12; 95 % CI: [1.73, 15.14]; p = 0.003).
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Conclusions: ACF can be effective in reaching vulnerable populations and mitigating the socioeconomic burden of
TB, and can contribute to achieving the WHO End TB Strategy goals. Nevertheless, as TB remains a catastrophic life
event, social protection efforts must extend beyond ACF.
Keywords: Tuberculosis, Catastrophic costs, Active case finding, Social protection, Patient cost survey, Longitudinal
design, Viet Nam
Background
Tuberculosis (TB) disproportionally affects the poorest
segments of society [1]. Economically and socially vul-
nerable persons are at higher risk of TB infection and
progression to active TB disease [2–4]. Previous research
has also shown that TB exacerbates poverty [5–7]. Thus,
one of the three targets included in the WHO End TB
Strategy is the elimination of catastrophic costs, defined
as incurring expenses in excess of 20 % of annual house-
hold income, due to TB [8].
Despite recent rapid economic development, Viet
Nam remains a high TB burden country. There were
170,000 incident cases and 11,400 TB-related mortalities
in 2019 [9]. Viet Nam conducted its first national TB pa-
tient cost survey in 2016 [10]. This cross-sectional sur-
vey sampled 677 drug-susceptible (DS-TB) and 58
multi-drug resistant TB (MDR-TB) patients. The pro-
portion of DS-TB patients who experienced catastrophic
costs was 63 %, while the catastrophic costs prevalence
among MDR-TB patients was 98 % [11]. Following the
national survey, the National TB Control Program
(NTP) explored and developed various social protection
mechanisms for TB patients. Most notable is the estab-
lishment of a national patient support fund named the
Patient Support Foundation to End Tuberculosis to pay
for Social Health Insurance (SHI) enrollment and
unreimbursed medical costs.
With a treatment coverage rate of 60 %, there remains
a pool of undetected TB and sustained transmission in
the community [9]. Active case finding (ACF) is a strat-
egy to find people with TB earlier in their disease course
and in larger numbers, particularly among vulnerable
populations [12]. If implemented consistently, ACF has
the potential to reduce TB transmission and improve
health outcomes over time [13]. Based on these epidemi-
ologic benefits, the NTP has placed a strong emphasis
on ACF in the recent past [14–17]. However, to date the
evidence on the socio-protective nature of ACF remains
limited [18, 19] with none available for the Vietnamese
context.
This study aimed to assess the socioeconomic im-
pact and socio-protective potential of ACF by
obtaining a longitudinal measure of the financial
burden of DS-TB treatment and comparing costs in




This cross-sectional study fielded a longitudinal cost
survey from March 2018 to March 2019 alongside an
intervention. The intervention consisted of ACF
among household and close contacts, and persons liv-
ing in presumptive hotspots, boarding homes and
urban slums implemented by community health
workers (CHW). All household contacts and other
targeted persons with symptoms suggestive of TB
were referred for chest x-ray screening and sputum
testing by rapid molecular assay or smear microscopy.
The CHWs supported patients to initiate and adhere
to treatment. Patients in the PCF districts received
routine care as per national treatment guidelines. The
intervention is described in detail elsewhere [20, 21].
Study setting
The study took place in 12 districts of Ho Chi Minh City
(HCMC), Viet Nam (Fig. 1). Six districts implemented a
community-based ACF intervention. The remaining six
districts served as control areas where people with TB
were passively detected through routine program activ-
ities (PCF). In 2017, the intervention area had a popula-
tion of 2,814,034 and notified 4,159 TB patients, while
the control area had a population of 1,789,396 and noti-
fied 2,859 TB patients [22]. This represented a case noti-
fication rate (CNR) of 148 per 100,000 and 160 per
100,000, respectively.
Participant recruitment and sample size
The study employed a consecutive sampling approach in
both cohorts. Patients entered into TB treatment regis-
ters were referred by District TB Unit staff for recruit-
ment to participate on the study. We included
pulmonary DS-TB patients 18 years and older who re-
sided in the study area. We excluded persons treated in
the private sector or declined to participate.
We estimated a sample size of 100 patients equally
distributed between ACF and PCF cohorts. The sample
size was based on a 63 % catastrophic cost incurrence
rate among DS-TB patients [11]. We estimated an 80 %
power to show a 50 % reduction in catastrophic costs
from ACF [12] at 95 % confidence, and with 25 % con-
tingency for loss to follow-up.
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Data collection
We developed a longitudinal adaptation of the WHO
survey instrument used in Viet Nam’s national patient
cost survey to measure patient cost and socioeconomic
impact throughout TB treatment and limit recall bias
(supplementary material) [23]. We expanded the survey’s
asset list with items relevant in the contemporary urban
Vietnamese context. The questionnaire assessed partici-
pant characteristics, financial and economic costs, and
socioeconomic impact associated with TB. The latter in-
cluded changes in employment status, food insecurity,
productivity loss, social exclusion and use of coping
strategies. Clinical data such as TB diagnosis and treat-
ment information were extracted from patient registers.
In Viet Nam, new and relapse DS-TB patients typically
take treatment for six months. The intensive phase lasts
two months and the continuation phase lasts four
months. Costs and social impact were measured thrice
in both ACF and PCF cohorts to cover the pre-
treatment, intensive and continuation phases. The first
interview took place after at least two weeks of treat-
ment and covered the period from the onset of symp-
toms to the time of the interview. The second and third
interviews occurred after completion of the intensive
and continuation phases, respectively (Fig. 2).
Interviewers captured responses through audio record-
ings and on paper. Data were digitized using web-forms
on the ONA platform (ONA Systems, Nairobi, Kenya);
digital data were checked against the paper surveys to
ensure data entry accuracy. All costs were collected in
Viet Nam Dong (VNĐ) and converted to US dollars
(US$) using the average 2018–2019 exchange rates re-
ported by OANDA for the study period (VNĐ1 =
US$0.0000436) [24].
Data analysis
Participant characteristics and health-seeking behaviors
We presented participant demographic, clinical and so-
cioeconomic characteristics. We employed an adapted
multidimensional poverty index for TB (MPI-TB) using
the Alkire-Foster method to profile a participant’s socio-
economic status [25–27]. The MPI-TB construct was
designed as an absolute measure with thresholds mirror-
ing those of Viet Nam’s national MPI, and is further de-
tailed in the supplementary material. Health-seeking
behavior was summarized by frequency and type of
healthcare provider visited.
Patient income and costs
For each treatment period, we collected monthly per-
sonal and household income and estimated direct med-
ical, direct non-medical and indirect costs incurred.
Direct medical costs included medications, diagnostic
tests, consultations and hospitalization fees. Direct non-
medical costs included spend on transportation and
food. Indirect cost consisted of income loss, which was
self-reported by the patient. For those patients who
could not provide this information, we calculated in-
come loss by using the self-reported number of working
hours/days lost multiplied by the hourly (US$0.90) or
Fig. 1 Location of sampling districts in Ho Chi Minh City, Viet Nam
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daily (US$7.00) minimum wage for Region 1 in Viet
Nam [28]. Indirect costs, time lost traveling to health fa-
cilities and waiting for an appointment were calculated
by multiplying the number of hours lost by the hourly
minimum wage. Total indirect cost was calculated by
summing the monetary value of the time and income
lost. We excluded caregiver time-loss for consistency
with the national TB patient cost survey [11] and pa-
tients lost to follow-up after the first interview.
Socioeconomic impact
We reported the frequency of financial coping mecha-
nisms used, loss of employment, reduction in work
hours, lower wage levels or the transfer to a lower pay-
ing position or job. We estimated ratios of catastrophic
costs and poverty headcount. To estimate catastrophic
cost, we applied the WHO definition [10] of total costs
exceeding 20 % of the average annual household income
before this episode of TB. We applied the poverty head-
count defined by the World Bank as US$1.90 per day
with an annual purchasing power parity conversion fac-
tor for Gross Domestic Product at 2017 prices as defined
by the World Bank [29, 30].
Statistical approach
Chi-square and Fisher’s exact tests were used to deter-
mine statistical differences in proportions of categorical
variables. Wilcoxon rank-sum tests were used to com-
pare median costs between the ACF and PCF cohorts.
We excluded missing data and reported denominators
that deviated from the total sample size. Univariate and
multivariate logistic models were fitted to measure the
association between catastrophic costs incurrence and
ACF/PCF cohort alongside other demographic and
socioeconomic patient characteristics. Differences in so-
cioeconomic impact and catastrophic costs in individual
treatment periods were analyzed by fitting univariate
population-averaged logistic regression models using
generalized estimation equation methods with working
correlation structures based on Quasi-likelihood Infor-
mation Criteria. Hypothesis tests were two-sided. P-
values below 0.05 were considered statistically signifi-
cant. Data analysis was performed in Stata v15 (Stata-
Corp, College Station, TX, USA).
Ethical considerations
Approvals were granted by the Liverpool School of Trop-
ical Medicine Research Ethics Committee (17–019) and
Pham Ngoc Thach Provincial TB Hospital Institutional
Review Board (430/HDDD-PNT). The implementation of
the interventions was approved by the HCMC People’s
Committee (214/QD-UBND, 2138/QD-UBND, 2878/QD-
UBND). The NTP approved use of programmatic treat-
ment data. All protocols were carried out in accordance
with relevant guidelines and regulations. Before the inter-
view, we provided a written participant information sheet,
a verbal explanations of the study and an opportunity to
ask questions to ensure all participants were aware of the
study. All participants provided informed written consent.
All data were anonymized prior to analysis.
Results
Participant characteristics
One-hundred invited individuals agreed to participate in
the survey, but two did not complete the final interview.
Thus, the final study sample consisted of 98 participants,
46 PCF and 52 ACF, for a total of 294 survey encoun-
ters. Most patients were male (62/98 = 63 %) (Table 1).
Fig. 2 Survey timeline and participant retention
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ACF patients tended to be slightly older than PCF pa-
tients (52 vs. 45; p = 0.063). The ACF cohort had fewer
individuals with a secondary school degree (54 % vs.
78 %; p = 0.011) and more individuals whose income fell
in the poorest tertile (43 % vs. 22 %; p = 0.003). The share
of people enrolled onto SHI in the ACF cohort was sig-
nificantly lower than in the PCF cohort (69 % vs. 91 %;
p = 0.007). The depth-adjusted MPI-TB ratio among
ACF patients was significantly higher than among PCF
patients (15.5 % vs. 7.1 %; p = 0.033).









Male, N (%) 33 (63) 29 (63) 62 (63) 0.966
Age, mean (SD), years 51.8 (15.7) 44.8 (17.9) 48.5 (17.0) 0.063
Complete secondary school, N (%) 28 (54) 36 (78) 64 (65) 0.011*
Employed before the episode of TB, N (%) 39 (75) 33 (72) 72 (73) 0.715
Patient income pre-TB, N (%)a
Poorest 22 (43) 10 (22) 32 (33) 0.003*
Moderate 18 (35) 14 (31) 32 (33) 0.714
Wealthiest 13 (25) 19 (42) 32 (33) 0.072
Household income pre-TB, N (%)a
Poorest 21 (40) 12 (27) 33 (34) 0.155
Moderate 18 (35) 14 (31) 32 (33) 0.714
Wealthiest 13 (25) 19 (42) 32 (33) 0.072
Social Health Insurance, N (%) 36 (69) 42 (91) 78 (80) 0.007*
Adjusted MPI-TB headcount ratio, mean (SD)b 15.5 (21.8) 7.1 (15.9) 11.6 (19.6) 0.033*
TB diagnosis and treatment
TB/HIV co-infection, N (%) 0 (0) 3 (7) 3 (3) 0.061
New TB case, N (%) 35 (67) 44 (96) 79 (81) < 0.001*
Bacteriologically confirmed, N (%) 52 (100) 43 (93) 95 (97) 0.061
Time between onset of TB symptoms and treatment initiationc, mean (SD), weeks 9.1 (8.9) 12.7 (18.2) 11.0 (14.5) 0.245
Hospitalization pre-treatment, N (%) 3 (6) 10 (22) 13 (13) 0.020*
Hospitalization during treatment, N (%) 3 (6) 6 (13) 9 (9) 0.213
Number of follow-up visits during treatment, mean (SD) 3.3 (1.0) 3.5 (1.0) 3.4 (1.0) 0.402
Type of service visited, pre-treatment, N (%)d
Private sector 31/262 (12) 79/366 (22) 110/628 (18) 0.002*
Non-NTP public sector 34/262 (13) 140/366 (38) 174/628 (28) < 0.001*
NTPe 110/262 (42) 63/366 (17) 173/628 (28) < 0.001*
Othersf 87/262 (33) 84/366 (23) 171/628 (27) < 0.004*
Type of service visited, treatment, N (%)d
Private sector 8/234 (3) 25/273 (9) 33/507 (7) 0.009*
Non-NTP public sector 75/234 (32) 57/273 (21) 132/507 (26) 0.004*
NTPe 2/234 (1) 40/273 (15) 42/507 (8) < 0.001*
Othersf 149/234 (64) 151/273 (55) 300/507 (59) 0.056
aBased on within-sample tertiles of self-reported incomes;
bHeadcount ratio calculated based on a deprivation threshold of 33 % (> 5 deprivations) as adapted from official guidelines on multi-dimensional poverty defined
by the Government of Viet Nam with further detail provided in the supplementary material;
cContains nine missing values in the ACF cohort with N = 43;
dTotal number of visits during the pre-treatment (ACF = 262, PCF = 366, Total = 628) and treatment periods (ACF = 234, PCF = 273, Total = 507);
eNTP National TB Control program;
fTraditional healers, herbalists, pharmacists and mobile X-ray events (pre-treatment, only);
gChi-square, Fischer Exact (any cell with n < 5 in the contingency table) for proportions, Wilcoxon Rank Sum for medians, t-test for means
* Statistically significant difference at 95 % confidence level
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Health-seeking behaviors
There were fewer new TB patients in the ACF cohort
(67 % vs. 96 %; p < 0.001) and fewer pre-treatment
hospitalizations (6 % vs. 22 %; p = 0.003) than among
PCF patients. ACF patients reported fewer visits to
health facilities before initiating treatment (262 vs.
366) with a significantly higher share of ACF patients
accessing NTP services compared PCF patients (42 %
vs. 17 %; p < 0.001). Conversely, the rate of health-
seeking in non-NTP public healthcare facilities (13 %
vs. 38 %; p < 0.001) and private healthcare providers
(12 % vs. 22 %; p = 0.002) was significantly lower in
ACF patients.
Patient income and costs
Prior to TB treatment, the monthly median personal in-
come was significantly lower in the ACF cohort com-
pared to the PCF cohort in the pre-treatment (US$153
vs. US$283; p = 0.004) and continuation phase (US$133
vs. US$240; p = 0.037) (Fig. 3a). During the intensive
phase the median personal income declined sharply
from US$153 to US$65 in the ACF cohort and from
US$283 to US$109 in the PCF cohort, but recovered to
pre-TB levels by the end of treatment. Median house-
hold income was lower in the ACF cohort than in the
PCF cohort in all periods, but these differences were not
significant. The household income changes followed the
same pattern as observed on personal income, declining
during the intensive phase and recovering by the end of
the treatment (Fig. 3b).
Table 2 shows the mean and median costs incurred
during the pre-treatment and treatment periods as well
as the total costs and income losses incurred due to the
episode of TB. The median total costs incurred by ACF
patients during the pre-treatment period was signifi-
cantly lower compared to PCF patients (US$18 vs.
US$80; p < 0.001). Specifically, patients in the ACF co-
hort incurred significantly lower direct medical costs
compared to the PCF cohort (US$13 vs. US$75;, p <
0.001). Once TB treatment began, there was no
Fig. 3 Variation in income by treatment period and study cohort. a) Personal income. b) Household income
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significant difference in direct, indirect or total costs be-
tween the ACF and PCF cohorts.
Overall, ACF patients incurred significantly fewer total
costs than PCF patients (US$279 vs. US$894; p < 0.001),
and significantly lower indirect costs (US$115 vs.
US$460; p = 0.003) and income loss (US$71 vs. US$414;
p = 0.032).
Socioeconomic impact
Fewer ACF patients incurred catastrophic costs than
PCF patients (15 % vs. 30 %) and ACF patients had sig-
nificantly lower odds of catastrophic cost (aOR = 0.17;
95 % CI: [0.05, 0.67]; p = 0.011) (Table 3). This lower rate
of catastrophic cost incurrence in the ACF cohort was
evident across all individual treatment periods (Table 4).
Particularly during the intensive phase, catastrophic cost
incurrence was significant lower in the ACF cohort com-
pared to PCF cohort (OR = 0.32; 95 % CI: [0.12–0.90];
p = 0.030).
Participants in the ACF cohort further showed a sig-
nificantly lower risk of social exclusion during the con-
tinuation phase (OR = 0.40; 95 % CI: [0.18–0.91]; p =
0.030). However, patients in the ACF cohort also had a
significantly higher risk of resorting to financial coping
mechanisms during the continuation phase (OR = 5.12;
95 % CI: [1.73–15.14]; p = 0.003).
Discussion
We found that ACF significantly reduced catastrophic
cost incurrence. Specifically, the study showed a lower
proportion and odds of households experiencing cata-
strophic cost in the ACF cohort compared to the
PCF cohort. This was potentially due the higher un-
employment and income loss in the PCF cohort,
which subsequently amplified the socio-protective ef-
fects of ACF. This is concordant with findings from
other settings [12, 31].
Compared to the country [11] and region [32], the
catastrophic cost prevalence in our study was lower.
This was likely due to situating the study in HCMC, the
economic center of Viet Nam [33, 34]. We measured
substantially higher average monthly household incomes
in our survey (US$483) than in the national patient cost
survey (US$322) [11]. A survey in Indonesia observed a
similar effect when dichotomizing catastrophic cost in-
currence between poor and non-poor TB patients [35].
Table 2 Mean and median direct and indirect costs during pre-treatment and treatment periods for TB patients in the ACF and PCF
cohorts (VNĐ1 = US$0.0000436, 2018-2019)
Cost item ACF (N = 52) PCF (N = 46) All (N = 98) P-valuea
Mean (95% CI) Median (IQR) Mean (95% CI) Median (IQR) Mean (95% CI) Median (IQR)
Pre-treatment
Direct medical 37 (18-56) 13 (4-31) 151 (70-231) 75 (30-168) 90 (50-130) 29 (11-81) <0.001*
Direct non-medical 7 (2-12) 2 (0-4) 6 (3-9) 3 (1-8) 7 (4-9) 2 (1-6) 0.1394
Total directb 44 (22-66) 17 (6-34) 155 (73-238) 78 (32-154) 96 (55-137) 34 (11-88) <0.001*
Indirect, time loss 5 (0-10) 1 (0.5-1) 20 (3-36) 2 (1-5) 12 (4-20) 1 (1-3) <0.001*
Total pre-treatment 49 (24-74) 18 (7-37) 175 (85-264) 80 (33-203) 108 (63-153) 35 (13-90) <0.001*
Treatment
Direct medical 54 (39-70) 34 (22-61) 384 (76-693) 76 (37-154) 209 (63-355) 47 (24-93) <0.001*
Direct non-medical 44 (31-57) 27 (12-59) 43 (14-71) 14 (8-38) 43 (29-58) 20 (10-47) 0.056
Total directb 98 (74-122) 66 (43-121) 427 (98-756) 90 (50-195) 253 (97-408) 83 (46-160) 0.067
Indirect, time loss 13 (7-20) 6 (4-13) 27 (1-53) 5 (4-8) 20 (7-33) 5 (4-11) 0.144
Total treatment 112 (85-139) 73 (47-143) 454 (105-804) 95 (55-202) 273 (108-438) 91 (50-174) 0.109
Total costs (pre-treatment + treatment)
Direct medical 91 (68-115) 62 (34-123) 535 (169-902) 166 (98-289) 230 (125-474) 105 (47-196) <0.001*
Direct non-medical 51 (37-65) 34 (14-73) 48 (19-79) 19 (13-44) 50 (34-65) 23 (13-59) 0.095
Total Direct 142 (84-139) 106 (72-200) 582 (205-925) 179 (99-351) 349 (153-505) 131 (84-258) 0.001*
Income loss 273 (145-400) 71 (0-272) 627 (384-869) 414 (0-931) 439 (304-573) 134 (0-761) 0.032*
Time loss 18 (10-27) 8 (5-15) 47 (11-83) 9 (6-23) 32 (14-49) 8 (5-19) 0.693
Total Indirect 291 (163.7-419.0) 115 (12-307) 674 (436-912) 460 (59-938) 471 (337-605) 166 (23-765) 0.003*
Total costs 434 (301-566) 279 (122-468) 1,256 (807-1,706) 894 (234-1359) 820 (587-1,053) 413 (168-1,046) <0.001*
aWilcoxon Rank Sum;
bNet value: reimbursement deducted
* Statistically significant difference at 95 % confidence level
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As catastrophic cost incurrence is defined on the basis
of household income [36], the temporary loss of one
source of income may have been compensated by the
remaining household members in our setting. Therefore,
it will be important to assess the productivity of the
other household members, when evaluating vulnerability
to catastrophic cost incurrence and optimizing eligibility
for social protection mechanisms.
One critical yet underemphasized benefit of ACF is
the ability to reach more marginalized populations and
increase equity in TB care [31, 37]. Our study’s ACF ac-
tivities evinced similar benefits as we reached more so-
cioeconomically disadvantaged groups, who more
commonly lacked basic essentials and access to social
protection mechanisms. TB patients in the ACF cohort
more commonly resorted to financial coping mecha-
nisms to manage the socioeconomic burden of TB. As
such, it was encouraging to observe that our ACF activ-
ities optimized the TB care pathway. ACF patients re-
ported fewer health-seeking events before treatment and
fewer hospitalizations than PCF patients. ACF patients
also more frequently sought care directly with the NTP,
while PCF patients tended to access several healthcare
providers before finally reaching the NTP [38].
It may be that the ACF cohort was unable to afford
other alternatives, and therefore were receptive to the
CHW’s referral to the NTP. This is also supported by
our finding that ACF did not significantly reduce the
time between symptom onset and treatment initiation,
i.e., diagnostic delays, as observed in other settings
[39]. Particularly, the hypothesis is that ACF patients
were significantly poorer and as such potentially de-
layed accessing healthcare altogether until approached
and counseled by a CHW. Meanwhile, the PCF co-
hort visited private and non-NTP public providers at
a higher rate prior to reaching the NTP. This
optimization of the patient pathway is a key socio-
protective effect of ACF that has also been docu-
mented elsewhere [40–42].
The reduction in health facility visits resulting
from CHW referrals to the NTP optimized the pa-
tient pathway and likely helped to reduce costs
among ACF patients. A systematic review of TB-
related patient costs in sub-Saharan Africa shows
that policies and programs improving access to
healthcare has the potential to reduce pre-treatment
costs, though the optimal modality for reducing
costs to patients remains unknown [43]. ACF
Table 3 Association between catastrophic costs and baseline characteristics for the entire episode of TB







PCFa 13/44 (30) 1.00 1.00
ACF 8/52 (15) 0.43 (0.16–1.17) 0.17 (0.05–0.67)*
Sex
Femalea 6/35 (30) 1.00 1.00
Male 15/61 (25) 1.58 (0.55–4.52) 1.65 (0.49–5.53)
Age categoryb
≤50 yearsa 9/51 (18) 1.00 1.00
>50 years 12/45 (27) 1.70 (0.64–4.51) 2.09 (0.67–6.52)
Education level
Up to primary school onlya 11/33 (33) 1.00 1.00
Secondary school and above 10/63 (16) 0.38 (0.14–1.02) 0.15 (0.04–0.60)*
Employment status
Unemployeda 4/25 (16) 1.00 1.00
Employed 17/71 (24) 1.65 (0.50–5.49) 4.14 (0.83–20.76)
Social Health Insurance status
Uninsureda 5/20 (25) 1.00 1.00
Insured 16/76 (21) 0.80 (0.25–2.53) 0.78 (0.19–3.23)
aReferent;
bAge>50 years (mean age for pooled sample);
cN=96;
dDenotes participants that incurred catastrophic costs over the total number of people in a given subgroup;
eMultivariate logistic regression incorporating all shown patient covariates (i.e., case finding model, sex, etc.) as exposure parameters for the model
* Statistically significant difference at 95 % confidence level
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patients also reported significantly fewer costs from
lost income. Past studies identified this category as a
major source of economic burden for TB patients
[11, 44]. A reason may be that the socio-protective
effects of community-based ACF do not end after
enrollment. Patient support provided by CHWs
throughout treatment, especially during the intensive
phase, can ameliorate economic burdens as well.
This included collection and transport of sputum for
follow-up testing and provision of counseling and
psychosocial support. These services were offered
free of charge thereby alleviating any associated costs
for the patient. Our study also found that ACF pa-
tients incurred significantly lower direct medical
costs during treatment. PCF patients reported more
additional visits to private providers during the treat-
ment phase (see Table 1), which resulted in higher
costs from medical fees and consultations. While our
health economic evaluation of these activities is on-
going, they comprise well-documented benefits of
community-based care [45, 46].
It is important to note that within our study sam-
ple, the PCF cohort reported significantly higher
pre-treatment individual and household incomes.
However, once TB was diagnosed and treatment
commenced we observed no significant differences
between the PCF and ACF cohorts. This either sug-
gests that TB had a greater impoverishing effect on
PCF patients or could also mean that better socio-
economic conditions afforded the freedom to forego
income-generating activities. This is supported by
the higher rates of formal employment among PCF
patients, who were more likely to benefit from statu-
tory job protections, such as paid sick leave and pro-
tection from unlawful termination [47].
Through the longitudinal design of our study, we were
able to observe a near-full recovery of household income
loss and employment in both cohorts during the con-
tinuation phase. The recovery was likely a consequence
of TB patients returning to work to recover from the
loss in productivity experienced during the illness,
whether it was related to directly observed treatment,
TB-related disability or statutory leave during the inten-
sive phase. A similar longitudinal survey conducted
among ACF and PCF TB patients in Nepal did not show
any income recovery during treatment. This discordance
was possibly a result of Viet Nam’s stronger economy,
which offered more employment options after the










































Catastrophic costsa 8 (15) 13 (30) 0.43
(0.16–
1.17)
8 (22) 17 (46) 0.32
(0.12–
0.90)*
11 (22) 12 (27) 0.76
(0.30–1.93)
10 (20) 10 (22) 0.86
(0.32–
2.29)
Unemployed 5 (10) 8 (17) 0.51
(0.15–
1.67)
15 (29) 21 (46) 0.48
(0.21–1.11)
10 (19) 10 (22) 0.86
(0.32–2.29)
7 (13) 9 (20) 0.64
(0.22–
1.88)
Poverty headcountb 11 (21) 8 (17) 1.27
(0.46–
3.51)
22 (42) 19 (41) 1.04
(0.47–2.33)
12 (23) 10 (22) 1.08
(0.42–2.80)





NA NA NA 21 (66) 11 (34) 2.16
(0.90–5.17)
19 (41) 27 (59) 0.41
(0.18–0.91)*





NA NA NA 15 (29) 18 (39) 0.63
(0.27–1.47)
12 (23) 16 (35) 0.56
(0.23–1.36)
8 (15) 11 (24) 0.58
(0.21–
1.59)
Financial impactc NA NA NA 29 (56) 18 (39) 1.96
(0.87–4.39)
27 (52) 20 (43) 1.40
(0.63–3.11)
19 (37) 19 (41) 0.82
(0.36–
1.84)
Coping strategies NA NA NA 14 (27) 7 (15) 2.05
(0.75–5.64)
20 (38) 5 (11) 5.12
(1.73–
15.14)*
15 (29) 11 (24) 1.29
(0.51–
3.18)
aCatastrophic costs calculated according to the income reported in each period of analysis;
bPoverty line established by the World Bank = $1.90, International Dollar ($) applying purchase power parity (PPP), 2017 prices, conversion factor = $7,716.43;
cPatients indicating that they were poorer or much poorer as a result of their episode of TB;
dUnivariate odds ratio accounting for autocorrelation using generalized estimation equation methods with working correlation structure obtained using quasi-
likelihood information criteria
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completion of TB treatment, a greater ability for TB pa-
tients to re-enter the job market, and to recover from
the deleterious socioeconomic impact of TB.
The socioeconomic burden throughout individual
treatment phases requires further investigation, but
our findings that the burden was highest during the
intensive phase may inform and optimize social pro-
tection mechanisms. As attention to social protection
schemes, such as cash transfers, is increasing, [48] it
may be worthwhile to systematically compare the ef-
fects of providing social support during the intensive
phase only versus throughout the full treatment
course. This approach has the potential to optimize
resource allocation for social protection schemes.
Our study was subject to recall and social desirabil-
ity bias. We believe the longitudinal design of the
survey and audit of receipts mitigated the impact of
these limitations, but also required a concerted effort
to remind patients of the period in question when
assessing costs, as well as time and income losses. Fo-
cusing solely on HCMC biased our data towards a
higher socioeconomic class and limited the
generalizability of our findings in the national and
international context. As the study was conducted
under programmatic conditions, patient follow-up was
periodically affected by supply chain and program ir-
regularities. Through close collaboration with the pro-
vincial and national TB control programs, we tried to
minimize the impact of these irregularities.
Conclusions
ACF can be effective in reaching vulnerable popula-
tions and mitigating the socioeconomic burden of TB.
Programs should consider ACF a key strategy to sup-
port TB-affected families and achieve the WHO End
TB Strategy goals. Nevertheless, as TB remains a
catastrophic life event, social protection efforts must
extend beyond ACF. Given resource limitations, it
may be possible to focus these efforts on TB patients
in the intensive phase of treatment so that more TB–
affected families can receive support.
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